Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J. Zost(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Paul W. Rothlauf(Harvard University), Luke Myers(Vanderbilt University Medical Center), David R. Martinez(University of North Carolina at Chapel Hill), Robert H. Carnahan(Vanderbilt University Medical Center), Doan C. Nguyen(Emory University), Rachel E. Sutton(Vanderbilt University Medical Center), Ralph S. Baric(University of North Carolina at Chapel Hill), F. Eun‐Hyung Lee(Emory University), Swathi Shrihari(Washington University in St. Louis), Pavlo Gilchuk(AstraZeneca (Japan)), Larissa B. Thackray(Washington University in St. Louis), James Brett Case(Washington University in St. Louis), Rachel S. Nargi(Vanderbilt University Medical Center), Elad Binshtein, Naveenchandra Suryadevara(Vanderbilt University), Rita E. Chen(Washington University in St. Louis), Louis-Marie Bloyet(Washington University in St. Louis), Andrew Trivette, Mario Ostrowski(St. Michael's Hospital), Jonathan E. Didier, Joseph X. Reidy(Vanderbilt University Medical Center), Michael Diamond(Washington University in St. Louis), Elaine C. Chen(Vanderbilt University Medical Center), Taylor Jones(Vanderbilt University Medical Center), Sean P. J. Whelan(University of Pittsburgh Medical Center), Igñacio Sanz(Emory University), Samuel B. Day(Vanderbilt University Medical Center), Keith W. MacRenaris, Helen Y. Chu(Seattle Pacific University)
Cited by 543
Related Papers
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k